Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marshall BioResources is one of the world’s largest breeders and suppliers of purpose-bred animals—primarily beagles and ferrets—for use in biomedical and veterinary preclinical research. Its animals have contributed to the development and safety testing of numerous human medicines, vaccines, medical devices, and companion animal pharmaceuticals over more than 80 years. The company operates globally with facilities accredited by AAALAC International and ISO 9001 certified. It has faced criticism from animal rights groups regarding welfare standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marshall BioResources.